Symbicort® (Budesonide/Formoterol) Pharmacy Program

In November 2019, Kos designed, developed, and implemented the Symbicort® (Budesonide/Formoterol) Pharmacy. AstraZeneca Pty Ltd is pleased to introduce the Program with PharmaPrograms. The primary aim of the Program is to support medication compliance and adherence for both asthma and COPD patients via tailored Quality Use of Medicines (QUM) information.